Exact Mass: 486.208
Exact Mass Matches: 486.208
Found 500 metabolites which its exact mass value is equals to given mass value 486.208
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Austalide I
Austalide I is a mycotoxin from the food storage mould (Aspergillus ustus Mycotoxin from the food storage mould (Aspergillus ustus).
15-Acetoxyscirpene-3,4-diol 4-O-a-D-glucopyranoside
15-Acetoxyscirpene-3,4-diol 4-O-a-D-glucopyranoside is from Fusarium sulphureu From Fusarium sulphureum
Glucosylgalactosyl hydroxylysine
Glucosylgalactosyl hydroxylysine is a Glycoside of hydroxylysine. Hydroxylation of lysine is an important post-translational modification of collagen, (PMID 10928217) a reaction catalyzed by the enzyme Lysyl hydroxylase (EC 1.14.11.4) forming hydroxylysine in collagens and other proteins with collagen-like amino acid sequences, by the hydroxylation of lysine residues in X-lys-gly sequences. The hydroxylysine residues formed in the lysyl hydroxylase reaction have 2 important functions: first, their hydroxy groups serve as sites of attachment for carbohydrate units, either the monosaccharide galactose or the disaccharide glucosylgalactose; and second, they are essential for the stability of the intermolecular collagen crosslinks. (OMIM 153454). Hydroxylysine-deficient skin collagen is manifested in Ehlers-Danlos syndrome, type VIA, A heritable disorder of connective tissue (PMID 5016372). Glucosylgalactosyl hydroxylysine is a Glycoside of hydroxylysine. Hydroxylation of lysine is an important post-translational modification of collagen, (PMID 10928217) a reaction catalyzed by the enzyme Lysyl hydroxylase (EC 1.14.11.4) forming hydroxylysine in collagens and other proteins with collagen-like amino acid sequences, by the hydroxylation of lysine residues in X-lys-gly sequences.
2-O-alpha-D-Glucopyranosyl-O-beta-D-galactopyranosylhydroxylysine
Antibiotic LL-AB 664
Apadenoson
N-(4-Cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide
MRS 1754 is a selective antagonist radioligand for A2B adenosine receptor with very low affinity for A1 and A3 receptors of both humans and rats[1].
Catharanthine tartrate
4-[6-[(6-O-Acetyl-beta-D-glucopyranosyl)oxy]-3-methyl-2-oxohexyl]dihydro-3-methylene-5-(2-oxopropyl)-2(3H)-furanone
Artelastochromene
2-{O3-carbamoyl-2-[(N-formimidoyl-glycyl)-methyl-amino]-beta-D-2-deoxy-gulopyranosylamino}-7-hydroxy-5-methyl-1(3),3a,5,6,7,7a-hexahydro-imidazo[4,5-c]pyridin-4-one
6-O-(4-methoxybenzoyl)crescentin IV 3-O-beta-D-glucopyranoside
1-(4-beta-D-glucopyranosyloxybenzyl) 4-ethyl (2R)-2-isobutylmalate
(2S)-5-hydroxy-2-(5-hydroxy-3,4-dimethoxyphenyl)-8-(4-hydroxy-4-methylpentyl)-8-methyl-2,3,7,8-tetrahydropyrano[3,2-g]chromen-4(6H)-one|Tomentin C
2-hydroxy-4-(2-hydroxy-4-methoxy-6-(2-oxoheptyl)benzoyloxy)-6-pentylbenzoic acid
(2S)-5-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-8-(4-hydroxy-4-methylpentyl)-8-methyl-2,3,7,8-tetrahydropyrano[3,2-g]chromen-4(6H)-one|Tomentin D
3-deoxo-1,2-dihydro-3-hydroxy-(2beta,3beta)-daphnetoxin
(+)-4-(3-methylbutanoyl)-2,6-di(3,4-dimethoxy)phenyl-3,7-dioxabicyclo[3.3.0]octane
2-methyl-1-[2,4,6-trihydroxy-3-[1-(4-hydroxy-6-methoxy-1,3-benzodioxol-5-yl)-2-methylpropyl]-5-(3-methyl-2-butenyl)phenyl]-1-propanone
Catharanthine tartrate
C27H34O8_Methyl [(1S,3S,7R,8R,9R,12S,13S)-13-(3-furyl)-6,6,8,12-tetramethyl-17-methylene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.0~1,12~.0~3,8~]heptadec-7-yl](hydroxy)acetate
methyl (2R)-2-[(1S,3S,7R,8R,9R,12S,13R)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]-2-hydroxyacetate
(2R,2R,4aS,6S,7R,8aS)-6,7-diformyl-4-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-2H,3H-spiro[benzofuran-2,1-naphthalene]-6,7-diyl diacetate
Ala Ala Tyr Tyr
Ala Cys Phe Phe
Ala Phe Cys Phe
Ala Phe Phe Cys
Ala Phe Ser Tyr
Ala Phe Tyr Ser
Ala His Pro Tyr
Ala His Tyr Pro
Ala Asn Pro Trp
Ala Asn Trp Pro
Ala Pro His Tyr
Ala Pro Asn Trp
Ala Pro Trp Asn
Ala Pro Tyr His
Ala Ser Phe Tyr
Ala Ser Tyr Phe
Ala Trp Asn Pro
Ala Trp Pro Asn
Ala Tyr Ala Tyr
Ala Tyr Phe Ser
Ala Tyr His Pro
Ala Tyr Pro His
Ala Tyr Ser Phe
Ala Tyr Tyr Ala
Cys Ala Phe Phe
Cys Phe Ala Phe
Cys Phe Phe Ala
Asp Pro Gln Gln
Asp Gln Pro Gln
Asp Gln Gln Pro
Glu His Thr Thr
Glu Asn Pro Gln
Glu Asn Gln Pro
Glu Pro Asn Gln
Glu Pro Gln Asn
Glu Gln Asn Pro
Glu Gln Pro Asn
Glu Thr His Thr
Glu Thr Thr His
Phe Ala Cys Phe
Phe Ala Phe Cys
Phe Ala Ser Tyr
Phe Ala Tyr Ser
Phe Cys Ala Phe
Phe Cys Phe Ala
Phe Phe Ala Cys
Phe Phe Cys Ala
Phe Phe Ser Ser
Phe Gly Thr Tyr
Phe Gly Tyr Thr
Phe His Pro Ser
Phe His Ser Pro
Phe Pro His Ser
Phe Pro Ser His
Phe Ser Ala Tyr
Phe Ser Phe Ser
Phe Ser His Pro
Phe Ser Pro His
Phe Ser Ser Phe
Phe Ser Tyr Ala
Phe Thr Gly Tyr
Phe Thr Tyr Gly
Phe Tyr Ala Ser
Phe Tyr Gly Thr
Phe Tyr Ser Ala
Phe Tyr Thr Gly
Gly Phe Thr Tyr
Gly Phe Tyr Thr
Gly His His His
Gly Pro Gln Trp
Gly Pro Trp Gln
Gly Gln Pro Trp
Gly Gln Trp Pro
Gly Thr Phe Tyr
Gly Thr Tyr Phe
Gly Trp Pro Gln
Gly Trp Gln Pro
Gly Tyr Phe Thr
Gly Tyr Thr Phe
His Ala Pro Tyr
His Ala Tyr Pro
His Glu Thr Thr
His Phe Pro Ser
His Phe Ser Pro
His Gly His His
His His Gly His
His His His Gly
His Ile Met Ser
His Ile Ser Met
His Leu Met Ser
His Leu Ser Met
His Met Ile Ser
His Met Leu Ser
His Met Ser Ile
His Met Ser Leu
His Met Thr Val
His Met Val Thr
His Pro Ala Tyr
His Pro Phe Ser
His Pro Ser Phe
His Pro Tyr Ala
His Ser Phe Pro
His Ser Ile Met
His Ser Leu Met
His Ser Met Ile
His Ser Met Leu
His Ser Pro Phe
His Thr Glu Thr
His Thr Met Val
His Thr Thr Glu
His Thr Val Met
His Val Met Thr
His Val Thr Met
His Tyr Ala Pro
His Tyr Pro Ala
Ile His Met Ser
Ile His Ser Met
Ile Met His Ser
Ile Met Ser His
Ile Ser His Met
Ile Ser Met His
Leu His Met Ser
Leu His Ser Met
Leu Met His Ser
Leu Met Ser His
Leu Ser His Met
Leu Ser Met His
Met His Ile Ser
Met His Leu Ser
Met His Ser Ile
Met His Ser Leu
Met His Thr Val
Met His Val Thr
Asn Ala Pro Trp
Asn Ala Trp Pro
Asn Glu Pro Gln
Asn Glu Gln Pro
Asn Pro Ala Trp
Asn Pro Glu Gln
Asn Pro Gln Glu
Asn Pro Trp Ala
Asn Gln Glu Pro
Asn Gln Pro Glu
Asn Trp Ala Pro
Asn Trp Pro Ala
Pro Ala His Tyr
Pro Ala Asn Trp
Pro Ala Trp Asn
Pro Ala Tyr His
Pro Asp Gln Gln
Pro Glu Asn Gln
Pro Glu Gln Asn
Pro Phe His Ser
Pro Phe Ser His
Pro Gly Gln Trp
Pro Gly Trp Gln
Pro His Ala Tyr
Pro His Phe Ser
Pro His Ser Phe
Pro His Tyr Ala
Pro Asn Ala Trp
Pro Asn Glu Gln
Pro Asn Gln Glu
Pro Asn Trp Ala
Pro Gln Asp Gln
Pro Gln Glu Asn
Pro Gln Gly Trp
Pro Gln Asn Glu
Pro Gln Gln Asp
Pro Gln Trp Gly
Pro Ser Phe His
Pro Ser His Phe
Pro Trp Ala Asn
Pro Trp Gly Gln
Pro Trp Asn Ala
Pro Trp Gln Gly
Pro Tyr Ala His
Pro Tyr His Ala
Gln Asp Pro Gln
Gln Asp Gln Pro
Gln Glu Asn Pro
Gln Glu Pro Asn
Gln Gly Pro Trp
Gln Gly Trp Pro
Gln Asn Glu Pro
Gln Asn Pro Glu
Gln Pro Asp Gln
Gln Pro Glu Asn
Gln Pro Gly Trp
Gln Pro Asn Glu
Gln Pro Gln Asp
Gln Pro Trp Gly
Gln Gln Asp Pro
Gln Gln Pro Asp
Gln Trp Gly Pro
Gln Trp Pro Gly
Ser Ala Phe Tyr
Ser Ala Tyr Phe
Ser Phe Ala Tyr
Ser Phe Phe Ser
Ser Phe His Pro
Ser Phe Pro His
Ser Phe Ser Phe
Ser Phe Tyr Ala
Ser His Phe Pro
Ser His Pro Phe
Ser Pro Phe His
Ser Pro His Phe
Ser Ser Phe Phe
Ser Tyr Ala Phe
Ser Tyr Phe Ala
Thr Glu His Thr
Thr Glu Thr His
Thr Phe Gly Tyr
Thr Phe Tyr Gly
Thr Gly Phe Tyr
Thr Gly Tyr Phe
Thr His Glu Thr
Thr His Thr Glu
Thr Thr Glu His
Thr Thr His Glu
Thr Tyr Phe Gly
Thr Tyr Gly Phe
Trp Ala Asn Pro
Trp Ala Pro Asn
Trp Gly Pro Gln
Trp Gly Gln Pro
Trp Asn Ala Pro
Trp Asn Pro Ala
Trp Pro Ala Asn
Trp Pro Gly Gln
Trp Pro Asn Ala
Trp Pro Gln Gly
Trp Gln Gly Pro
Trp Gln Pro Gly
Tyr Ala Ala Tyr
Tyr Ala Phe Ser
Tyr Ala His Pro
Tyr Ala Pro His
Tyr Ala Ser Phe
Tyr Ala Tyr Ala
Tyr Phe Ala Ser
Tyr Phe Gly Thr
Tyr Phe Ser Ala
Tyr Phe Thr Gly
Tyr Gly Phe Thr
Tyr Gly Thr Phe
Tyr His Ala Pro
Tyr His Pro Ala
Tyr Pro Ala His
Tyr Pro His Ala
Tyr Ser Ala Phe
Tyr Ser Phe Ala
Tyr Thr Phe Gly
Tyr Thr Gly Phe
Tyr Tyr Ala Ala
Austalide I
15-Acetoxyscirpene-3,4-diol 4-O-a-D-glucopyranoside
N^a-Boc-N^w-(4-Methoxy-2,3,6-triMethylphenylsulfonyl)-D-arginine
3,5-O-(1,1,3,3-TETRAISOPROPYL-1,3-DISILOXANEDIYL)URIDINE
N-(4-(phenyl-9H-carbazol-3-yl)phenyl)biphenyl-4-aMine
2-[5-chloro-2-(4-chlorophenyl)-1H-indol-3-yl]-N,N-dihexylacetamide
4-[bis(2-methylpropyl)sulfamoyl]-N-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide
N-(2-Aminoethyl)-N~2~-{(1s)-1-[4-(Aminosulfonyl)biphenyl-4-Yl]-2,2,2-Trifluoroethyl}-L-Leucinamide
[5-[[2-(aminomethylideneamino)acetyl]-methylamino]-4-hydroxy-2-(hydroxymethyl)-6-[(7-hydroxy-5-methyl-4-oxo-3a,6,7,7a-tetrahydro-1H-imidazo[4,5-c]pyridin-2-yl)amino]oxan-3-yl] carbamate
3-deamino-3-hydroxykanamycin X
A kanamycin that is kanamycin X in which the 3-amino group has been replaced by a hydroxy group.
N-(2,2-Dimethyl-5-morpholin-4-yl-1,4-dihydro-2H-3,7-dithia-6,9,11-triaza-benzo[c]fluoren-8-yl)-N,N-diet hyl-ethane-1,2-diamine
[(1S,2R,9R,10R,11S)-10-Hydroxy-1,5-dimethyl-11-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-2-yl]methyl acetate
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(3-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-1-phenylmethanesulfonamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(3-methoxyphenyl)triazol-1-yl]ethyl]oxan-3-yl]-1-phenylmethanesulfonamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-methoxyphenyl)triazol-1-yl]ethyl]oxan-3-yl]-1-phenylmethanesulfonamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(3-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-1-phenylmethanesulfonamide
N-[(1R,3S,4aR,9aS)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-1-phenylmethanesulfonamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(3-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-1-phenylmethanesulfonamide
N-[(1R,3R,4aR,9aS)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aR,9aS)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aR,9aS)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
(1R,9S,10S,11S)-12-N-(2,5-difluorophenyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-11-N-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
(1S,9R,10R,11R)-12-N-(2,5-difluorophenyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-11-N-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
4-Ethoxycarbonyl-3-[3-(ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]benzoic acid
methyl (2R)-2-[(1S,3S,7R,8R,12S,13S)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.01,12.03,8]heptadecan-7-yl]-2-hydroxyacetate
MRS 1754
MRS 1754 is a selective antagonist radioligand for A2B adenosine receptor with very low affinity for A1 and A3 receptors of both humans and rats[1].
5-[(alpha-D-glucopyranosyl-(1->2)-beta-D-galactopyranosyl)oxy]-L-lysine
An O-glycosyl amino acid that is L-lysine in which one of the methylene hydrogens at position 5 has been replaced by an (alpha-D-glucopyranosyl-(1->2)-beta-D-galactopyranosyl)oxy group.
Catharanthine (Tartrate)
Catharanthine Tartrate is an alkaloid isolated from Catharanthus roseus, inhibits voltage-operated L-type Ca2+ channel, with anti-cancer and blood pressure-lowering activity[1]. Catharanthine Tartrate is an alkaloid isolated from Catharanthus roseus, inhibits voltage-operated L-type Ca2+ channel, with anti-cancer and blood pressure-lowering activity[1].
TAN-452
TAN-452 is an orally active, selective peripherally acting δ-opioid receptor (DOR) antagonist with a Ki of 0.47?nM and a Kb of 0.21?nM. TAN-452 is an antagonist for μ-opioid receptor (MOR; Ki=36.56?nM and Kb=9.43?nM) and κ-opioid receptor (KOR; Ki=5.31?nM and Kb=7.18?nM). TAN-452, a derivative of Naltrindole, demonstrates low brain penetrability and attenuates morphine-induced side effects without affecting pain control[1].
2-({15-[(1-carboxy-2-methylpropyl)-c-hydroxycarbonimidoyl]-1-hydroxypentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene}amino)butanedioic acid
methyl (2r)-2-[(1r,2s,5r,6r,13s,14r,16s)-6-(furan-3-yl)-14-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-16-yl]-2-hydroxyacetate
(9r,10r,11s)-19-hydroxy-3,4,5-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(19),2(7),3,5,12,14(18)-hexaen-11-yl 2-methylbutanoate
(1r,2r,3r,4s)-4-hydroxy-3-(hydroxymethyl)-4-methyl-2-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclopentyl 4-methoxybenzoate
4-hydroxy-3-(hydroxymethyl)-4-methyl-2-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclopentyl 4-methoxybenzoate
methyl (2e,3e,5e)-6-[3',3'-dimethyl-5'-(2-methylprop-1-en-1-yl)-3h-spiro[1,4-benzodioxine-2,2'-[1,4]dioxolan]-7-yl]-4-methoxy-2-(methoxymethylidene)-3-methylhexa-3,5-dienoate
(9s)-2,3,6-trihydroxy-4,5-dimethoxy-7-methyl-10-oxo-9h-anthracen-9-yl decanoate
(1r,5s,6r,14r,15s,17r,22s)-10,15-dihydroxy-6,14,18,18,22-pentamethyl-8,19-dioxo-7,13-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-3,9,11-trien-5-yl acetate
2,18-dimethyl (1s,9s,18s)-18-hydroxy-4,5-dimethoxy-21-oxo-2,12-diazapentacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸]henicosa-3(8),4,6,16(20)-tetraene-2,18-dicarboxylate
7a,9,11,11b-tetrahydroxy-3-(4-methoxyphenyl)-5a,8,8,11a-tetramethyl-6,7,9,10,11,12-hexahydro-2,5-dioxatetraphen-1-one
2,18-dimethyl (1s,9r,16r,17r,18r,21r)-17,18-dihydroxy-4,5-dimethoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3(8),4,6,14-tetraene-2,18-dicarboxylate
methyl 2-[(1s,3s,5r,7s,8r,10s,12s,13s)-13-(furan-3-yl)-5-hydroxy-6,6,8,12-tetramethyl-17-methylidene-9,15-dioxo-2,14-dioxatetracyclo[8.6.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate
10,15-dihydroxy-6,14,18,18,22-pentamethyl-8,19-dioxo-7,13-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-3,9,11-trien-5-yl acetate
[(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(4r)-4-methyl-6-[(2r,3r)-4-methylidene-5-oxo-2-(2-oxopropyl)oxolan-3-yl]-5-oxohexyl]oxy}oxan-2-yl]methyl acetate
(+)-4-(3-methylbutanoyl)-2,6-di(3,4-dimeth-oxy)phenyl-3,7-dioxabicyclo[3.3.0]octane
{"Ingredient_id": "HBIN009913","Ingredient_name": "(+)-4-(3-methylbutanoyl)-2,6-di(3,4-dimeth-oxy)phenyl-3,7-dioxabicyclo[3.3.0]octane","Alias": "NA","Ingredient_formula": "C27H34O8","Ingredient_Smile": "CC(C)CC(=O)OC1C2C(COC2C3=CC(=C(C=C3)OC)OC)C(O1)C4=CC(=C(C=C4)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14158","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}